a rogue scientist others say he's the man who may save the world from this real life pandemic jacob glanville is a computational immuno engineer he's also the co-founder and chief science officer of distributed bio and he joined me a little earlier to discuss this global crisis. you know engineers use math and computers to go into the start of. the program. special by engineering techniques assisted by computers to help us take all antibodies against the sars virus and adapt them to recognize and neutralize the company's 90000 bikers so as a scientist in this field what can you tell us about this novel coronavirus and if this strain and others are they occurring naturally. yes or something as if these are coming from natural sources it could be a barrier for some other creature coronaviruses are very big family of viruses and unfortunately this one is very infectious and humans and it's much more deadly than influenza so it's spreading pretty pretty quickly throughout the globe and we're transitioning. trying to stop it from getting into countries now and medication measures. already in the c

jacob glanville, distributed bio, his company. thank you, thank you. >>> the senate is now voting on that $100 billion phase two coronavirus bill. what we are going to do is let you know the final vote tally when we have it. we also have this. jpmorgan chase says it is planning to temporarily close about 20% of its branches. charlie gasparino predicted this. in fact, he broke that story a couple days ago. again, they are going to begin temporarily closing about 20% of their branches, not including the teller glass drive-up operations. jpmorgan says they will be paying branch employees for their regularly scheduled hours. still, the stock, not catching any kind of bid here, down 13.8% to $80.77. >>> this breaking news. a trio of top auto makers doing their part to help stop the spread of coronavirus. ford and general motors, they already confirmed they will shut down all north american plants after tomorrow night's shift. they will close them until march 30th. but now it appears fiat chrysler will join them. a source telling fox bu

jacob glanville. thank you. >>> let's take a look at the big board.move through the highs. we are just off the session highs right now, the dow up 1,057 points, hovering close to 27,000 on the dow. >>> coming up next, why shares of jack daniels' parent aren't tasting as smooth as tennessee whiskey this hour. we will get into that. "the claman countdown" will be right back. ashley: investors in jack daniels' parent, brown-forman, drowning their sorrows, apparently. shares in the red after european sales of whiskey faltered due to the u.s. slapping new 25% tariffs on the imported liquors in the eu. that doesn't help at all. plus of course, new threats due to the coronavirus forcing the spirits maker to cut its full year guidance. that stock down modestly, down 1% in a very big rally day. >>> all right. connell mcshane joins us now. connell, even tennessee whiskey apparently sus accept i beliece coronavirus. connell: not a sad day for stocks, though. we will have it at the top of the hour. we are up and down and today we are up almost 1,000 points. we wi

scientist others say he may be the man who might save the world from this real life pandemic jacob glanville is a computational immuno engineer he is the co-founder and chief science officer at distributed bio and he's joining us now to discuss this global crisis jacob thank you so much for being with us so 1st can you explain to us exactly what a computational in you know engineer is and how that's a political to helping with coke at 19. so thanks for having me on again propagation you know engineers use math and computers to help analyze you can sense and so on the basis of it and seeing if you're using special bioengineering sex be assisted by computers to help us take all the antibodies against the sars virus and adapt them to recognize a neutralize the copays 19000 by so as a scientist in this bio field what can you tell us about this novel coronavirus and if this strain and others are they occurring naturally. yes or sumption is that these are coming from natural sources it could be a bat or some other creature that coronaviruses are very big family of viruses and unfortunately this on

of distributed bio jacob glanville who also features in the netflix docu series pandemic jake thanks for coming on to what is the latest on the search for the vaccine reports here are saying that the british government favors a herd immunity response to let the virus run through the population a little would you think of a yeah so the reason they're saying that is that there is currently no effective medicine and so they're just preparing for the inevitable that large numbers of people will get infected. if you can slow down the rate of new infections that's better than having them had all at once because if they had all at once then you overrun your hospital i see use and you know a problem people dying in the waiting rooms with respect to where the medicines are there may be some good news in april where we have a series of anti-virals that didn't work. well against people up but they may work well here and there some h.i.b. anti-virals in an anti malarial so any success on any one of those fronts gives us a working medicine the vaccine work is going to take much longer that's goin

jacob glanville. i hope you keep us posted. thank you. thank you doctor. i am also -- thanks for being here. dr. jennifer is an epidemiologist, senior scholar. we've got all kinds of brilliant people here tonight. she will talk to about the actual facts of what's going on here. doctor, thank you. thanks for being here. >> things were happening. >> martha: today, when president trump and the task force came out, they talked about this. originally, the president said it's available now, but then we heard from the fda that it actually needs a little bit more time and more testing. what can you tell us about that situation and that drug and whether or not you think it's going to work and when? >> yeah, so this is a drug that is used for other conditions. it is used to treat arthritis. it is also used to battle certain infections. but we haven't found the studies that are necessary to understand the extent to which you could help treat people with the coronavirus. so, i'm really excited that the federal government is at the highest levels supporting research in

jacob glanville. he was featured in the netflix documentary "pandemic." he is working on a cure.s on handling the coronavirus where it can go from here. the all-important last hour of trading. i will try not to blow this rally and do my best not to. charles: thank you, ash. make sure you tune into the "claman countdown." it is the most exciting hour of the market at the top of the hour. >>> while health care stocks are popping, there is cautious tone to this market, folks. next i have two guys who know a thing or two about making money. they will tell us what we need to know as we head into the final hour of trading. maybe have we hit a bottom? we'll be right back. flexshares may look simple on the outside. but inside every etf... there are untold hours of careful construction... infinite "what ifs?" and contingency plans. creating funds that help target gaps in client portfolios. tap untapped potential. and strengthen confidence in you. flexshares. powered by over a century of investment expertise before investing consider the fund's investment objectives, risks, charges and exp

jacob glanville of distributed bio.p with a therapy that involves six different types of antibodies and he is ready, april 13th, it's going to be tested with two arms of the military. here's how he describes that it will work. >> the way it works, you take a patient who is sick and inject or infuse the antibody. within 20 minutes, that would be in their body and that would help neutralize the virus so they don't get sick. liz: you are hearing about a lot of different vaccines and therapies. how does that one sound? how does everything out there sound? >> yeah, so all of my colleagues in infectious disease and epidemiology are working, obviously everyone knows aggressively. there will be a lot of iterations of the science that have to be proven in patients, in human beings. what will be the eventual best approach will pan out as this effort continues. but things like what you have just shown, the vaccine, all those efforts are going to come together to produce what the most effective vehicle is. liz: we heard today from